Professor | Menglong Wang | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Menglong Wang
Contact Information	whuwangmenglong@163.com
Language ability	English, Chinese
Province	Hubei

Upload Avatar (500 x 500)

Name

Menglong Wang

Contact Information

whuwangmenglong@163.com

Language ability

English, Chinese

Province

Hubei

University/Lab Affiliation and Title	Wuhan University
Faculty	Medical School
Academic Background & Achievements	2007-2012 Bachelor of Clinical Medicine: Wuhan University 2012-2015 Master of Internal Medicine: Wuhan University 2015-2018 PhD in Internal Medicine: Wuhan University 2017-2018 Visiting Scholar at University of California, Los Angeles Presided over one youth foundation of National Natural Science Foundation of China, one Hubei Natural Science Foundation project, and one Central University Basic Research Fund project
Work Experience	2018.07-2018.11 Resident Physician, Department of Cardiology, Renmin Hospital of Wuhan University 2018.12-2020.06 Attending Physician, Department of Cardiology, Renmin Hospital of Wuhan University 2020.07-present Associate Chief Physician, Department of Cardiology, Renmin Hospital of Wuhan University
Awards	2018 First Prize, Science and Technology Progress Award of Hubei Province 2022 Second Prize, Science and Technology Progress Award of Hubei Province

University/Lab Affiliation and Title

Wuhan University

Faculty

Medical School

Academic Background & Achievements

2007-2012 Bachelor of Clinical Medicine: Wuhan University
2012-2015 Master of Internal Medicine: Wuhan University
2015-2018 PhD in Internal Medicine: Wuhan University
2017-2018 Visiting Scholar at University of California, Los Angeles
Presided over one youth foundation of National Natural Science Foundation of China, one Hubei Natural Science Foundation project, and one Central University Basic Research Fund project

Work Experience

2018.07-2018.11 Resident Physician, Department of Cardiology, Renmin Hospital of Wuhan University
2018.12-2020.06 Attending Physician, Department of Cardiology, Renmin Hospital of Wuhan University
2020.07-present Associate Chief Physician, Department of Cardiology, Renmin Hospital of Wuhan University

Awards

2018 First Prize, Science and Technology Progress Award of Hubei Province
2022 Second Prize, Science and Technology Progress Award of Hubei Province

Areas of Focus	Role and mechanism of inflammation resolution in cardiovascular diseases Regulatory effects of central neuroimmune response in cardiovascular diseases
Publications	Resolvin D2 and its receptor GPR18 in cardiovascular and metabolic diseases: a promising biomarker and therapeutic target, Zhao M, Zheng Z, Yin Z, Zhang J, Qin J, Wan J, Wang M, 2023 Scavenger Receptors in Myocardial Infarction and Ischemia/Reperfusion Injury: The Potential for Disease Evaluation and Therapy, Zhang J, Ding W, Liu J, Wan J, Wang M, 2023 TRPA1 deficiency attenuates cardiac fibrosis via regulating GRK5/NFAT signaling in diabetic rats, Wang M, Zhao M, Xu S, Zheng Z, Zhang J, Pan W, Yin Z, Liu J, Wei C, Wan J, Xu Y, 2023 Microglia-Mediated Neuroimmune Response Regulates Cardiac Remodeling After Myocardial Infarction, Wang M, Zhang J, Yin Z, Ding W, Zhao M, Liu J, Xu Y, Xu S, Pan W, Wei C, Jiang H, Wan J, 2023 Developmental endothelial locus-1 in cardiovascular and metabolic diseases: A promising biomarker and therapeutic target, Zhao M, Zheng Z, Li C, Wan J, Wang M, 2022 Mechanisms of efferocytosis in determining inflammation resolution: Therapeutic potential and the association with cardiovascular disease, Zhang J, Ding W, Zhao M, Liu J, Xu Y, Wan J, Wang M, 2022 MCC950, a Selective NLRP3 Inhibitor, Attenuates Adverse Cardiac Remodeling Following Heart Failure Through Improving the Cardiometabolic Dysfunction in Obese Mice, Wang M, Zhao M, Yu J, Xu Y, Zhang J, Liu J, Zheng Z, Ye J, Wang Z, Ye D, Feng Y, Xu S, Pan W, Wei C, Wan J, 2022 Resolvin D1 Attenuates Doxorubicin-Induced Cardiotoxicity by Inhibiting Inflammation, Oxidative and Endoplasmic Reticulum Stress, Wang M, Zhang J, Zhao M, Liu J, Ye J, Xu Y, Wang Z, Ye D, Li D, Wan J, 2022 Resolvin D1 protects against sepsis-induced cardiac injury in mice, Wang M, Liu M, Zhang J, Liu J, Ye J, Xu Y, Wang Z, Ye D, Zhao M, Wan J, 2020 Clinical Features of COVID-19 in Patients With Essential Hypertension and the Impacts of Renin-angiotensin-aldosterone System Inhibitors on the Prognosis of COVID-19 Patients, Pan W, Zhang J, Wang M, Ye J, Xu Y, Shen B, He H, Wang Z, Ye D, Zhao M, Luo Z, Liu M, Zhang P, Gu J, Liu M, Li D, Liu J, Wan J, 2020

Areas of Focus

Role and mechanism of inflammation resolution in cardiovascular diseases
Regulatory effects of central neuroimmune response in cardiovascular diseases

Publications

Resolvin D2 and its receptor GPR18 in cardiovascular and metabolic diseases: a promising biomarker and therapeutic target, Zhao M, Zheng Z, Yin Z, Zhang J, Qin J, Wan J, Wang M, 2023
Scavenger Receptors in Myocardial Infarction and Ischemia/Reperfusion Injury: The Potential for Disease Evaluation and Therapy, Zhang J, Ding W, Liu J, Wan J, Wang M, 2023
TRPA1 deficiency attenuates cardiac fibrosis via regulating GRK5/NFAT signaling in diabetic rats, Wang M, Zhao M, Xu S, Zheng Z, Zhang J, Pan W, Yin Z, Liu J, Wei C, Wan J, Xu Y, 2023
Microglia-Mediated Neuroimmune Response Regulates Cardiac Remodeling After Myocardial Infarction, Wang M, Zhang J, Yin Z, Ding W, Zhao M, Liu J, Xu Y, Xu S, Pan W, Wei C, Jiang H, Wan J, 2023
Developmental endothelial locus-1 in cardiovascular and metabolic diseases: A promising biomarker and therapeutic target, Zhao M, Zheng Z, Li C, Wan J, Wang M, 2022
Mechanisms of efferocytosis in determining inflammation resolution: Therapeutic potential and the association with cardiovascular disease, Zhang J, Ding W, Zhao M, Liu J, Xu Y, Wan J, Wang M, 2022
MCC950, a Selective NLRP3 Inhibitor, Attenuates Adverse Cardiac Remodeling Following Heart Failure Through Improving the Cardiometabolic Dysfunction in Obese Mice, Wang M, Zhao M, Yu J, Xu Y, Zhang J, Liu J, Zheng Z, Ye J, Wang Z, Ye D, Feng Y, Xu S, Pan W, Wei C, Wan J, 2022
Resolvin D1 Attenuates Doxorubicin-Induced Cardiotoxicity by Inhibiting Inflammation, Oxidative and Endoplasmic Reticulum Stress, Wang M, Zhang J, Zhao M, Liu J, Ye J, Xu Y, Wang Z, Ye D, Li D, Wan J, 2022
Resolvin D1 protects against sepsis-induced cardiac injury in mice, Wang M, Liu M, Zhang J, Liu J, Ye J, Xu Y, Wang Z, Ye D, Zhao M, Wan J, 2020
Clinical Features of COVID-19 in Patients With Essential Hypertension and the Impacts of Renin-angiotensin-aldosterone System Inhibitors on the Prognosis of COVID-19 Patients, Pan W, Zhang J, Wang M, Ye J, Xu Y, Shen B, He H, Wang Z, Ye D, Zhao M, Luo Z, Liu M, Zhang P, Gu J, Liu M, Li D, Liu J, Wan J, 2020

Inflammation Cardiovascular Mechanism Resolution Disease Neuroimmune Regulatory Response Research Clinical

Jinsong Bian - Southern University of Science and Technology

Chuanfeng Tong - Wuhan University

Jing Wan - Wuhan University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us